These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33589716)

  • 1. Machine learning modelling of blood lipid biomarkers in familial hypercholesterolaemia versus polygenic/environmental dyslipidaemia.
    Correia M; Kagenaar E; van Schalkwijk DB; Bourbon M; Gama-Carvalho M
    Sci Rep; 2021 Feb; 11(1):3801. PubMed ID: 33589716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR; Martin FJ; Spirk D
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.
    Rahman T; Hamzan NS; Mokhsin A; Rahmat R; Ibrahim ZO; Razali R; Thevarajah M; Nawawi H
    Lipids Health Dis; 2017 Apr; 16(1):81. PubMed ID: 28438163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The familial hypercholesterolaemia phenotype: Monogenic familial hypercholesterolaemia, polygenic hypercholesterolaemia and other causes.
    Mariano C; Alves AC; Medeiros AM; Chora JR; Antunes M; Futema M; Humphries SE; Bourbon M
    Clin Genet; 2020 Mar; 97(3):457-466. PubMed ID: 31893465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
    Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
    Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.
    Jarauta E; Pérez-Ruiz MR; Pérez-Calahorra S; Mateo-Gallego R; Cenarro A; Cofán M; Ros E; Civeira F; Tejedor MT
    J Clin Lipidol; 2016; 10(6):1397-1405.e2. PubMed ID: 27919357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid and lipoprotein parameters for detection of familial hypercholesterolemia in childhood. The DECOPIN Project.
    Plana N; Rodríguez-Borjabad C; Ibarretxe D; Ferré R; Feliu A; Caselles A; Masana L;
    Clin Investig Arterioscler; 2018; 30(4):170-178. PubMed ID: 29602595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland.
    Björnsson E; Thorgeirsson G; Helgadóttir A; Thorleifsson G; Sveinbjörnsson G; Kristmundsdóttir S; Jónsson H; Jónasdóttir A; Jónasdóttir Á; Sigurðsson Á; Guðnason T; Ólafsson Í; Sigurðsson EL; Sigurðardóttir Ó; Viðarsson B; Baldvinsson M; Bjarnason R; Danielsen R; Matthíasson SE; Thórarinsson BL; Grétarsdóttir S; Steinthórsdóttir V; Halldórsson BV; Andersen K; Arnar DO; Jónsdóttir I; Guðbjartsson DF; Hólm H; Thorsteinsdóttir U; Sulem P; Stefánsson K
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2616-2628. PubMed ID: 34407635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variance of Serum Lipid Levels in Stroke Subtypes.
    Yuan BB; Luo GG; Gao JX; Qiao J; Yang JB; Huo K; Li YB; Liu Y
    Clin Lab; 2015; 61(10):1509-14. PubMed ID: 26642713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia.
    Futema M; Bourbon M; Williams M; Humphries SE
    Atherosclerosis; 2018 Oct; 277():457-463. PubMed ID: 30270085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT).
    Weng SF; Kai J; Andrew Neil H; Humphries SE; Qureshi N
    Atherosclerosis; 2015 Feb; 238(2):336-43. PubMed ID: 25555265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision screening for familial hypercholesterolaemia: a machine learning study applied to electronic health encounter data.
    Myers KD; Knowles JW; Staszak D; Shapiro MD; Howard W; Yadava M; Zuzick D; Williamson L; Shah NH; Banda JM; Leader J; Cromwell WC; Trautman E; Murray MF; Baum SJ; Myers S; Gidding SS; Wilemon K; Rader DJ
    Lancet Digit Health; 2019 Dec; 1(8):e393-e402. PubMed ID: 33323221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
    Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL
    Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of simvastatin on plasma lipids and apolipoproteins in familial hypercholesterolemic swine.
    Hasler-Rapacz J; Kempen HJ; Princen HM; Kudchodkar BJ; Lacko A; Rapacz J
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):137-43. PubMed ID: 8548414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Contribution of GWAS Loci in Familial Dyslipidemias.
    Ripatti P; Rämö JT; Söderlund S; Surakka I; Matikainen N; Pirinen M; Pajukanta P; Sarin AP; Service SK; Laurila PP; Ehnholm C; Salomaa V; Wilson RK; Palotie A; Freimer NB; Taskinen MR; Ripatti S
    PLoS Genet; 2016 May; 12(5):e1006078. PubMed ID: 27227539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia.
    Miltiadous G; Xenophontos S; Bairaktari E; Ganotakis M; Cariolou M; Elisaf M
    Pharmacogenet Genomics; 2005 Apr; 15(4):219-25. PubMed ID: 15864114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
    Zambon A; Brown BG; Deeb SS; Brunzell JD
    J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein profile assessed by 2D-1H-NMR and subclinical atherosclerosis in children with familial hypercholesterolaemia.
    Rodríguez-Borjabad C; Ibarretxe D; Girona J; Ferré R; Feliu A; Amigó N; Guijarro E; Masana L; Plana N;
    Atherosclerosis; 2018 Mar; 270():117-122. PubMed ID: 29407879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
    Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
    J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parent-child genetic testing for familial hypercholesterolaemia in an Australian context.
    Pang J; Martin AC; Bates TR; Hooper AJ; Bell DA; Burnett JR; Norman R; Watts GF
    J Paediatr Child Health; 2018 Jul; 54(7):741-747. PubMed ID: 29626384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.